HomeTGNA • FRA
add
Transgene SA
Previous close
€0.59
Year range
€0.57 - €1.32
Market cap
80.96M EUR
Avg Volume
221.00
P/E ratio
-
Dividend yield
-
Primary exchange
EPA
In the news
Financials
Income Statement
Revenue
Net income
(EUR) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 1.50M | -4.49% |
Operating expense | 1.65M | -13.06% |
Net income | -8.74M | -172.11% |
Net profit margin | -583.64 | -184.91% |
Earnings per share | — | — |
EBITDA | -9.12M | -31.14% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(EUR) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 16.67M | 6.41% |
Total assets | 42.17M | -6.73% |
Total liabilities | 26.97M | -8.90% |
Total equity | 15.20M | — |
Shares outstanding | 131.93M | — |
Price to book | 4.95 | — |
Return on assets | -56.79% | — |
Return on capital | -93.55% | — |
Cash Flow
Net change in cash
(EUR) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -8.74M | -172.11% |
Cash from operations | -2.51M | 70.52% |
Cash from investing | -880.00K | -110.56% |
Cash from financing | 3.86M | -37.11% |
Net change in cash | 675.00K | -88.70% |
Free cash flow | -5.66M | -705.83% |
About
Founded
1979
Website
Employees
144